September 2015

Genticel, société française de biotechnologie, qui développe des immunothérapies innovantes pour prévenir les cancers induits par le virus du papillome humain (HPV), a annoncé qu'un nouveau brevet intitulé «Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response » a été accordé aux Etats-Unis.

08

Sep
2015
Commentaires fermés sur Un brevet américain pour Genticel
Innovation Days 2015 – Meet our latest speakers

Our international speakers will cover a 360° vision of the Biotech & Medtech sectors by debatting on the trending themes of Open Innovation, Market Access, Strategic Alliances, and Digitalization of Healthcare Services. Meet them during 5 & 6th october in Paris! Boost your company’s development by booking a booth space! As an Exhibitor, take advantage of the Innovation Days and Market Access Conference and increase

04

Sep
2015
Commentaires fermés sur Innovation Days 2015 – Meet our latest speakers

Bayer HealthCare a lancé le 21 août dernier son programme «Grants4Apps Accelerator» 2015 à Berlin. Grâce au soutien de l'entreprise, cinq startups du monde entier spécialisées dans la santé numérique vont développer leurs idées et stratégies commerciales pour apporter aux médecins, aux patients et aux consommateurs des logiciels, équipements et technologies innovants.

03

Sep
2015
Commentaires fermés sur Bayer HealthCare va soutenir cinq startups spécialisées dans la santé numérique

L'association a pour but de promouvoir le développement de l’industrie des biotechnologies et des sciences de la vie en France

02

Sep
2015
Commentaires fermés sur Facts & Figures Biotech- août 2015

Sanofi is lending its weight to Google's ambitions in life sciences, joining the tech giant's recently unleashed healthcare division in hopes of developing new technologies to help manage diabetes.

01

Sep
2015
Commentaires fermés sur Sanofi buys into Google’s biotech future, pairing up in diabetes
San Francisco biotech CytomX files for $100 million IPO

San Francisco-based biotech CytomX Theraputics has filed to raise $100 million for an initial public offering, a brief with the Securities and Exchange Commission shows . The company develops cancer immunotherapies that avoid healthy cells.

01

Sep
2015
Commentaires fermés sur San Francisco biotech CytomX files for $100 million IPO
August 2015

Biotechnology stocks are on track to beat the stock market for a remarkable fifth year straight. The largest biotech exchange-traded fund, iShares Nasdaq Biotechnology ETF (IBB), with more than $9 billion in assets, rallied an average of 36% the past five years vs. 10.4% for the SPDR S&P 500 ETF (SPY). [...]

13

Août
2015
Commentaires fermés sur A More Viable Way To Invest In Top-Performing Biotech Stocks

TRENTON, N.J. (AP) — Early research in older adults found an experimental vaccine prevented nearly two-thirds of serious cases of a common, seasonal respiratory virus that annually kills thousands of vulnerable Americans — babies and senior...

13

Août
2015
Commentaires fermés sur Novavax: Early study indicates its vaccine effective vs. RSV

Sorrento Therapeutics, closely allied with Patrick Soon-Shiong's fast-growing oncology drug empire, has bagged two private biotech companies, adding some CAR-T therapies to the mix.

12

Août
2015
Commentaires fermés sur Sorrento’s biotech buyouts bag CAR-T drugs

Jeremy Levin has stepped up with a $75 million round to back Phase II work on Ovid Therapeutics' lead drug for rare brain diseases as the ex-Teva chief executes on his plan to build a pipeline of experimental drugs in neurology.

12

Août
2015
Commentaires fermés sur Fidelity, Sanofi back $75M round for Jeremy Levin’s neurology startup

août 2015

Page 9 of 35« First...7891011...2030...Last »